Loading…
← Back to schedule
Unlocking Value in Underfunded Therapeutic Areas: Insights from Innoviva’s Strategic Acquisitions
Monday September 30, 2024 12:15pm - 12:45pm EDT
The Westin Boston Seaport District
This session will discuss the strategy behind Innoviva’s acquisitions of Entasis Therapeutics and La Jolla Pharmaceutical and the subsequent creation of Innoviva Specialty Therapeutics. Join us for an engaging discussion that will provide a deep dive on new business models and M&A strategies that look to breathe new innovation into traditionally underfunded indications with high unmet needs. Hear how the deal came together, the biggest roadblocks that were overcome, and advice for any companies looking to execute similar deals.
  • Explore the investment landscape around underappreciated therapeutic areas and the opportunities to address critical unmet needs while generating shareholder value.
  • Evaluate innovative new models, such as public-private partnerships, to improve investment in public health.
  • Gain actionable intelligence directly from dealmakers and learn how they are fueling growth by advancing solutions for critical public health priorities.
  • Analyze the success factors for building a sustainable business in the critical care and infectious disease, a historically challenging commercial market.
Presented by Innoviva
Moderators
avatar for Kara Miller

Kara Miller

Founder, Laurel Way Productions
Kara Miller is the founder of Laurel Way Productions She has moderated panels and spoken about innovation and entrepreneurship at events hosted by The International Women's Forum, PBS Digital Media for STEM, Harvard Medical School, Google, and MIT Sloan. She has taught at Babson College... Read More →
Speakers
avatar for Steve Basso

Steve Basso

President, Innoviva Specialty Therapeutics
Steve Basso brings more than 30 years of experience of financial leadership, primarily in the pharmaceutical industry. Prior to joining Innoviva, Mr. Basso served as the Chief Financial Officer and Chief Operating Officer at Cybrexa Therapeutics and has held a variety of financial... Read More →
avatar for Patricia Drake

Patricia Drake

Chief Commercial Officer, Innoviva Specialty Therapeutics
Patricia Drake is a highly accomplished life science professional with over thirty years of extensive U.S. and international experience managing commercial portfolios. Her strong leadership background encompasses commercial strategy, marketing, market access, sales and operations... Read More →
avatar for Pavel Raifeld, CFA

Pavel Raifeld, CFA

Chief Executive Officer, Innovivia
Pavel Raifeld, CFA, joined Innoviva as Chief Executive Officer in May 2020. Prior to that, Mr. Raifeld served on the investment team at Sarissa Capital Management LP, an investment management firm focused on improving strategies of companies to enhance shareholder value. Earlier... Read More →
Monday September 30, 2024 12:15pm - 12:45pm EDT
The Westin Boston Seaport District
  Main Stage

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Share Modal

Share this link via

Or copy link